Biophytis SA (BPTSY)
7.09
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Biophytis Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2019 | -0.4499M |
| March 31, 2019 | 2.089M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.5796M |
| March 31, 2018 | -0.1044M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.4499M
Minimum
Jun 2019
-0.4499M
Maximum
Jun 2019
-0.4499M
Average
-0.4499M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| DBV Technologies SA | -0.062M |
| Cellectis SA | 11.90M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | 29.24M |
| Akari Therapeutics PLC | 1.514M |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow | -14.21M |
| Free Cash Flow Yield | -1.23K% |